We consider the opportunity a strategic commitment to world class stem cell research.
MIAMI (PRWEB) November 04, 2014
Global Stem Cells Group, Inc. has been named exclusive distributor for Adistem medical solutions, and Adilyfe, a new regenerative medicine products company founded by Adistem Ltd. Scientific Founder Vasilis Paspaliaris, M.D. in Melbourne, Australia and set to launch in early 2015. Paspaliaris made the announcement at the First International Symposium on Stem Cells and Regenerative Medicine held in Buenos Aires, Argentina Oct. 2-4 and hosted by Global Stem Cells Group.
Adistem-Adilyfe will manufacture a group of products for use in stem cell treatments, therapies and training through the Adimarket Division of the Global Stem Cells Group. The timing is perfect for GSCG’s current expansion into Latin American countries including Colombia, Costa Rica, Chile, Mexico and Peru, according to Global Stem Cells Group CEO Benito Novas.
Vasilis, an accomplished biotech scientist, stem cell researcher and pharmaceutical consultant joined the Global Stem Cells Group Scientific Advisory Board, part of the Regenestem Network.
“As always, Dr. Paspaliaris brings excellence to stem cell research,” Novas says. “His work has already proven critical to improving the quality of life for a range of chronically ill patients all over the world.
“We are honored to be representing Adistem and AdiLyfe products in Latin America; we consider the opportunity a strategic commitment to world class stem cell research.”
Vasilis says he knew Global Stem Cells Group would be the only choice to represent Adistem and AdiLyfe in Latin America.
“We are proud of our relationship with Global Stem Cells Group, we couldn’t ask for better partners,” Vasilis says.
To learn more about the Global Stem Cells Group, visit the website at http://www.stemcellsgroup.com, email bnovas(at)stemcellsgroup(dot)com, or call 305.224.1858.
About Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
AdiStem Ltd. is a provider of photo-activation technology and medical solutions that assist in orthopedic, cosmetic, neurologic, pulmonary, metabolic and plastic/reconstructive surgery procedures.
The company owns proprietary technology for PRP procedures and for autologous adult adipose-derived stem cell isolation and administration. The use of AdiLight-2 for the photo activation of PRP requires no training. On the other hand, the adult stem cell technology is shared with qualified clinicians through instructional courses, workshops and seminars.
AdiStem has also isolated specific biomolecules from autologous adult adipose-derived stem cells that target a number of chronic diseases including HIV/Aids, Pain and Type II Diabetes.